Royal Bank of Canada Reiterates “Outperform” Rating for agilon health (NYSE:AGL)

Royal Bank of Canada reiterated their outperform rating on shares of agilon health (NYSE:AGL) in a research note released on Tuesday,Benzinga reports. They currently have a $3.00 target price on the stock.

A number of other equities analysts also recently commented on AGL. JMP Securities downgraded shares of agilon health from an “outperform” rating to a “market perform” rating in a research note on Monday, November 11th. William Blair downgraded shares of agilon health from an “outperform” rating to a “market perform” rating in a research note on Friday, November 8th. TD Cowen reduced their price objective on shares of agilon health from $6.00 to $2.00 and set a “hold” rating for the company in a research note on Monday, November 11th. Bank of America downgraded shares of agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price objective for the company. in a research note on Wednesday, October 2nd. Finally, Stifel Nicolaus reduced their price objective on shares of agilon health from $7.00 to $2.00 and set a “hold” rating for the company in a research note on Tuesday, November 12th. Three research analysts have rated the stock with a sell rating, fifteen have given a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $6.05.

agilon health Stock Up 6.2 %

Shares of NYSE AGL opened at $1.89 on Tuesday. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. The firm has a market capitalization of $778.72 million, a price-to-earnings ratio of -2.01 and a beta of 0.60. The stock has a 50 day moving average price of $2.88 and a 200 day moving average price of $4.74. agilon health has a 52-week low of $1.50 and a 52-week high of $13.76.

agilon health (NYSE:AGL) last announced its quarterly earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). The firm had revenue of $1.45 billion during the quarter, compared to analysts’ expectations of $1.47 billion. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. During the same quarter in the previous year, the firm posted ($0.06) EPS. Sell-side analysts expect that agilon health will post -0.47 earnings per share for the current year.

Insider Activity at agilon health

In other agilon health news, CEO Steven Sell purchased 20,000 shares of the stock in a transaction on Thursday, September 12th. The shares were bought at an average cost of $3.36 per share, with a total value of $67,200.00. Following the completion of the acquisition, the chief executive officer now owns 67,590 shares in the company, valued at $227,102.40. This trade represents a 42.03 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website. 3.20% of the stock is owned by insiders.

Institutional Investors Weigh In On agilon health

Several hedge funds have recently added to or reduced their stakes in the business. Arizona State Retirement System boosted its holdings in agilon health by 2.5% in the second quarter. Arizona State Retirement System now owns 85,989 shares of the company’s stock valued at $562,000 after purchasing an additional 2,070 shares during the last quarter. J.Safra Asset Management Corp boosted its holdings in agilon health by 626.1% in the second quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company’s stock valued at $27,000 after purchasing an additional 3,625 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. purchased a new stake in agilon health in the third quarter valued at $28,000. CWM LLC boosted its holdings in agilon health by 406.5% in the second quarter. CWM LLC now owns 9,081 shares of the company’s stock valued at $59,000 after purchasing an additional 7,288 shares during the last quarter. Finally, Signaturefd LLC boosted its holdings in agilon health by 166.2% in the second quarter. Signaturefd LLC now owns 11,848 shares of the company’s stock valued at $77,000 after purchasing an additional 7,398 shares during the last quarter.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.